Danish drugmaker Novo Nordisk has partnered with Hims & Hers Health's to sell its popular weight loss drug through a bundled ...

Eli Lilly, the drugmaker with two weight-loss bestsellers, just got its first dose of healthy skeptism during a time when the ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

Pfizer ( PFE) reported mixed first quarter earnings Tuesday, as the company struggles to gain investor interest in its ...

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

HSBC on Monday double downgraded Eli Lilly and Co. (LLY) stock to ‘Reduce’ from ‘Buy’ and also lowered its price target to ...

The first reveal of clinical data with Eli Lilly’s injectable triple receptor ... the data suggests a stronger weight-reducing effect than Novo Nordisk’s GLP-1 agonist Wegovy (semaglutide ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...